Desirudin is a direct inhibitor of human thrombin. It has a protein structure that is similar to that of hirudin, the naturally occurring anticoagulant present in the peripharyngeal glands in the medicinal leech, Hirudo medicinalis. Hirudin is a single polypeptide chain of 65 amino acids residues and contains three disulfide bridges. Desirudin has a chemical formula of C287H440N80O110S6 with a molecular weight of 6963.52.
It is mainly indicated for the prevention of deep vein thrombosis in hip replacement surgery patients.
Common side effects include: Bleeding gums, collection of blood under the skin, coughing up blood, deep, dark purple bruise and difficulty with breathing or swallowing.
Indicated as prophylaxis of deep vein thrombosis for patients undergoing hip replacement surgery.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.